UMAXLIFE

Umaxlife is a healthtech company transforming mental healthcare into an evidence-based, measurable practice. Its cloud-based AI platform analyzes wearable physiological data and speech patterns to objectively assess emotional and behavioral responses during therapy sessions. By integrating seamlessly with EHR systems, hospitals, and insurers, Umaxlife enables therapists and healthcare providers to measure treatment effectiveness, detect relapse risks early, and personalize care pathways. The company’s approach aligns with WHO’s global mental health action plan and the NHS’s mission to integrate mental health into primary care. Through AI-driven insights, Umaxlife bridges the data gap between mental and physical health, helping healthcare payers and insurers reduce costs while improving outcomes. Backed by TÜBİTAK R&D grants, Sanofi’s Care4Rare Award, and AWS Activate credits, Umaxlife is scaling its pilots across the UK, EU, and Turkey. The platform has already analyzed over 400 therapy sessions, demonstrating clinical relevance and strong B2B traction with universities and hospital networks. Mission: To make mental healthcare measurable, scalable, and integrated into every level of primary care. Business Model: B2B SaaS, API licensing, and AI analytics services for healthcare providers, insurers, and research institutions.

Domain

umaxlife.com

Country

United Kingdom

Industry

Mental Health

Employees

1-10

Last Funding

$0.1M

Founded

2023